Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Free Cash Flow of $387025.0 for Q1 2026, up 12694.21% sequentially from $3025.0 in Q4 2025, and down 89.95% YoY from $3.9 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Free Cash Flow for 17 years, with the latest figure at $387025.0 in Q1 2026.
- Quarterly Free Cash Flow fell 89.95% year-over-year to $387025.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 74.38% YoY) and the FY2025 annual result came in at $4.8 million, up 812.39% from the prior year.
- Free Cash Flow climbed to $387025.0 in Q1 2026 per CPIX's latest filing, from $3025.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $5.2 million in Q2 2023 and troughed at -$2.2 million in Q1 2024.
- A 5-year average of $1.1 million and a median of $817315.0 in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Free Cash Flow tumbled 759.5% in 2023, then surged 276.79% in 2025.
- Over 5 years, Free Cash Flow stood at $3.8 million in 2022, then sank by 73.85% to $991448.0 in 2023, then soared by 91.87% to $1.9 million in 2024, then tumbled by 99.84% to $3025.0 in 2025, then soared by 12694.21% to $387025.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $387025.0, $3025.0, and $163392.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | -3.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.92 Mn |
| Jun 30, 2026 | -3.92 Mn |
| Mar 31, 2026 | 387,025.00 |
| Mar 31, 2026 | 387,025.00 |
| Dec 31, 2025 | 3,025.00 |
| Dec 31, 2025 | 3,025.00 |
| Sep 30, 2025 | 163,392.00 |
| Sep 30, 2025 | 163,392.00 |
| Jun 30, 2025 | 817,315.00 |
| Jun 30, 2025 | 817,315.00 |
| Mar 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 460,124.00 |
| Sep 30, 2024 | 460,124.00 |
| Jun 30, 2024 | -862,838.00 |
| Jun 30, 2024 | -862,838.00 |
| Mar 31, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.18 Mn |